End-to-end automatic differentiation of the coronavirus disease 2019 (COVID-19) from viral pneumonia based on chest CT
Detection Principle
Imaging-CT scan
Target
CT-scans
Testing Method Category
In_silico
Testing Method
CT-scans and Jiangsu Shuoshi Biotechnology Co., Ltd. (Taizhou, China), Huada Biotechnology Co., Ltd. (Wuhan, China) RT-PCR kits
Testing Method - Additional Info
automatic differentiation method based on CT images to identify COVID-19 pneumonia patients in real time.
Reported Performance
sensitivity: 80% ; specificity: 75%
Sample Size
201 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements